Patents by Inventor Jose Miguel Lopez Novoa

Jose Miguel Lopez Novoa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9049856
    Abstract: The present invention relates to a cold organ preservation composition for transplantation comprising a cold organ preservation solution and cardiotrophin-1 or a functionally equivalent variant thereof. The invention also relates to methods and kits for the preparation of said composition, the uses thereof for the cold organ protection and/or preservation for transplantation (particularly for kidney, lung and heart) and also to the cold preservation methods and cold-preserved isolated organs by these methods.
    Type: Grant
    Filed: May 24, 2011
    Date of Patent: June 9, 2015
    Assignees: DIGNA ATOTECH, S. L., PROYECTO DE BIOMEDICINE CIMA, S.L.
    Inventors: Haisul C.Y. Chang, Victor Fernández Gallego, María Iñiguez Martínez, Jose Miguel López Novoa, Jesús María Prieto Valtueña, Juan Ruiz Echeverría
  • Publication number: 20140170125
    Abstract: The present invention relates to the use of cardiotrophin-1 (CT-1) for the prevention and/or treatment of acute renal injury, specially of acute kidney injury induced by nephrotoxic agents, such as contrast agents, antibiotics, immunosuppressive agents or antineoplastic agents. The invention is also related to compositions comprising said nephrotoxic agents and cardiotrophin-1.
    Type: Application
    Filed: August 10, 2012
    Publication date: June 19, 2014
    Applicant: DIGNA Biotech, S.L.
    Inventors: Begoña García Cenador, Javier García Criado, Francisco Javier López Hernández, Jose Miguel López Novoa, Maria Pilar Perez De Obanos Martell, Juan Ruiz Echeverría
  • Publication number: 20130130225
    Abstract: The present invention relates to a cold organ preservation composition for transplantation comprising a cold organ preservation solution and cardiotrophin-1 or a functionally equivalent variant thereof. The invention also relates to methods and kits for the preparation of said composition, the uses thereof for the cold organ protection and/or preservation for transplantation (particularly for kidney, lung and heart) and also to the cold preservation methods and cold-preserved isolated organs by these methods.
    Type: Application
    Filed: May 24, 2011
    Publication date: May 23, 2013
    Applicants: PROYECTO DE BIOMEDICINA CIMA, S.L., DIGNA BIOTECH, S.L.
    Inventors: Haisul C.Y. Chang, Victor Fernández Gallego, María Iñiguez Martínez, Jose Miguel Lopez Novoa, Jesús María Prieto Valtueña, Juan Ruiz Echeverría
  • Publication number: 20120129721
    Abstract: The invention relates to a method of determining the risk of developing acute renal failure (ARF) in an individual, or of determining an ARF, and a method of predicting the progression of an ARF, by detecting and/or quantifying the protein Ganglioside GM2 Activator Protein (GM2AP). The failure can be due to the administration of at least one nephrotoxic agent, wherein the nephrotoxic agent can be an aminoglycoside antibiotic as for example gentamicin.
    Type: Application
    Filed: May 26, 2009
    Publication date: May 24, 2012
    Applicant: UNIVERSIDAD DE SALAMANCA
    Inventors: Yaremi Quiros Luis, Laura Ferreira Redondo, Sandra María Sancho Martínez, José Manuel Gonzalez De Buitrago, Francisco Jose Lopez Hernandez, José Miguel Lopez Novoa